Endoscopy 2019; 51(12): 1183
DOI: 10.1055/a-0999-5452
Letter to the editor
© Georg Thieme Verlag KG Stuttgart · New York

Disputes about the efficacy of polyglycolic acid shielding for prevention of bleeding after endoscopic submucosal dissection

Authors

  • Chengfan Wang

    Digestive Endoscopy Department, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China
  • Lili Zhao

    Digestive Endoscopy Department, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China
  • Zhining Fan

    Digestive Endoscopy Department, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China
Further Information

Publication History

Publication Date:
27 November 2019 (online)

Preview

10.1055/a-0860-5280

Recently, Kataoka et al. [1] reported that polyglycolic acid (PGA) shielding had limited efficacy for the prevention of bleeding after endoscopic submucosal dissection (ESD). We would like to raise several concerns about this study and would appreciate the authors’ clarification of some details.

First, the authors reported that PGA sheet application was performed by one of two methods (step-by-step method and clip-and-pull method) according to each endoscopist. As claimed, the PGA sheet was first placed. What factors did the authors consider for the further fixation of fibrin glue? Would it be better to spray the fibrin first rather than coat the PGA sheet? Did the PGA sheet tightly cover the mucosa in bleeding cases? Tissue exudate and gastric acid might delay defect healing after ESD. As the foreign body, would the uncovered PGA sheet trigger hemorrhage of superficial vessels during oral intake? The post-operational nursing and endoscopic follow-up should be provided to explain early bleeding for PGA application [2] [3] [4].

Second, complete defect closure was suggested for ESD by the American Gastroenterological Association [5]. The large lesion and exposed defect might be the main cause of post-ESD bleeding. In our practice, clips or purse-suture methods are effective for defect closure and bleeding prevention. Would the authors consider this approach for the further comparison?

Third, we had some concerns about sample calculation. In the introduction, the authors stated that post-ESD bleeding was approximately 5 % with current prevention methods. But they applied 21 % bleeding in the control group during the statistical calculation for patient cohort size. Due to the small sample size, the superiority of PGA shielding was underestimated in this study. More patients should be enrolled to meet the statistical power and discriminate the intervention efficacy.